HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Generation and screening of oxime libraries addressing the neuronal GABA transporter GAT1.

Abstract
The objective of the present study was to transfer the concept of library screening by MS binding assays, so far applied to pseudostatic hydrazine libraries, to static oxime libraries to screen for new potent inhibitors of mGAT1, the most abundant GABA transporter in the central nervous system that represents a validated drug target for the treatment of epilepsy. Library generation was performed by reaction of guvacine derivatives possessing a hydroxylamine functionality with various sets of four aldehydes. After dilution, the libraries were screened by competitive MS binding assays. Deconvolution experiments allowed hits in the most active libraries to be identified, and they were resynthesized for biological evaluation. That way a series of compounds was identified that displayed binding affinities ≥8.00 (pKi ) at mGAT1, one of which was found to be the most potent mGAT1 inhibitor known to date in a functional GABA uptake assay with a pIC50 value of 8.27 ± 0.03.
AuthorsFelix T Kern, Klaus T Wanner
JournalChemMedChem (ChemMedChem) Vol. 10 Issue 2 Pg. 396-410 (Feb 2015) ISSN: 1860-7187 [Electronic] Germany
PMID25369775 (Publication Type: Journal Article)
Copyright© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Chemical References
  • GABA Plasma Membrane Transport Proteins
  • GABA Uptake Inhibitors
  • Oximes
  • gamma-Aminobutyric Acid
Topics
  • Combinatorial Chemistry Techniques
  • GABA Plasma Membrane Transport Proteins (chemistry, genetics, metabolism)
  • GABA Uptake Inhibitors (chemical synthesis, chemistry, metabolism)
  • HEK293 Cells
  • Humans
  • Kinetics
  • Oximes (chemical synthesis, chemistry, metabolism)
  • Protein Binding
  • Structure-Activity Relationship
  • gamma-Aminobutyric Acid (chemistry, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: